Tag: patent litigation
Paragraph IV Certification: How Generic Drugs Challenge Patents and Enter the Market
Learn how Paragraph IV certification under the Hatch-Waxman Act allows generic drugs to challenge patents and enter the market early, lowering costs for consumers.